Similar to previous studies, NSUN2 was indeed highly expressed in gastric cancer, ESCC and nasopharyngeal carcinoma [14, 15, 39], which indicated that NSUN2 might be highly expressed in other tumor types and can be used as a potential pan-cancer biomarker. The gene discussed is NSUN2; the disease is cancer.